Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas
Marco Lucioni(University of Pavia), Antonio Di Sabatino(University of Pavia), Marco Paulli(University of Milan), Luca Arcaini(University of Pavia), Monica Feltri(University of Pavia), Alessandro Vanoli(University of Pavia), Roberta Riboni(University of Pavia), Roberta Sciarra(Policlinico San Matteo Fondazione), Paola Bianchi(University of Pavia), Benedetto Neri(University of Rome Tor Vergata), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Giuseppina Ferrario(Policlinico San Matteo Fondazione), Nicola Aronico, Arturo Bonometti(Humanitas University), Gino Roberto Corazza(University of Pavia), Marco Vincenzo Lenti(University of Pavia), Giuseppe Neri, Sara Fraticelli(Humanitas University)
Cited by 14
Related Papers
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Decline with age of the respiratory chain activity in human skeletal muscle
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340
ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
|American Journal Of Pathology|1998|275